• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Protein phosphorylation regulates relative utilization of processing pathways for Alzheimer beta/A4 amyloid precursor protein.

作者信息

Gandy S E, Caporaso G L, Buxbaum J D, de Cruz Silva O, Iverfeldt K, Nordstedt C, Suzuki T, Czernik A J, Nairn A C, Greengard P

机构信息

Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York 10021.

出版信息

Ann N Y Acad Sci. 1993 Sep 24;695:117-21. doi: 10.1111/j.1749-6632.1993.tb23038.x.

DOI:10.1111/j.1749-6632.1993.tb23038.x
PMID:8239268
Abstract

The Alzheimer amyloid precursor protein (APP) is a phosphoprotein, and the phosphorylation state of APP at Ser655 can be regulated by protein kinase C, calcium/calmodulin-dependent protein kinase II, and okadaic acid-sensitive protein phosphatases. Other enzymes may also play a role at Ser655 of APP and, perhaps, at other residues. Signal transduction via protein phosphorylation regulates APP metabolism. In particular, APP processing via the nonamyloidogenic secretory cleavage pathway is increased following the activation of protein kinase C or the inactivation of okadaic acid-sensitive protein phosphatases. The mechanism(s) by which protein phosphorylation regulates APP secretory cleavage include (among others): substrate activation, substrate redistribution, protease activation and/or protease redistribution. Current experimental evidence will be discussed, addressing the relative importance of each of these possibilities and the implications for these events in the modulation of beta/A4-amyloidogenesis.

摘要

相似文献

1
Protein phosphorylation regulates relative utilization of processing pathways for Alzheimer beta/A4 amyloid precursor protein.
Ann N Y Acad Sci. 1993 Sep 24;695:117-21. doi: 10.1111/j.1749-6632.1993.tb23038.x.
2
Regulated cleavage of the Alzheimer amyloid precursor protein: molecular and cellular basis.阿尔茨海默病淀粉样前体蛋白的调控性切割:分子与细胞基础
Biochimie. 1994;76(3-4):300-3. doi: 10.1016/0300-9084(94)90162-7.
3
Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein.蛋白质磷酸化调节阿尔茨海默β/A4淀粉样前体蛋白的分泌。
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3055-9. doi: 10.1073/pnas.89.7.3055.
4
Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C.
Neuroscience. 1992 Jun;48(4):755-61. doi: 10.1016/0306-4522(92)90264-3.
5
The cytoplasmic domain of Alzheimer's amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells.在成年大鼠大脑和培养细胞中,阿尔茨海默病淀粉样前体蛋白的胞质结构域在苏氨酸654、丝氨酸655和苏氨酸668处发生磷酸化。
Mol Med. 1997 Feb;3(2):111-23.
6
Secretory processing of the Alzheimer amyloid beta/A4 protein precursor is increased by protein phosphorylation.蛋白质磷酸化可增强阿尔茨海默病淀粉样β/A4蛋白前体的分泌加工过程。
Biochem Biophys Res Commun. 1992 Sep 30;187(3):1285-90. doi: 10.1016/0006-291x(92)90442-n.
7
Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.阿尔茨海默β/A4淀粉样前体蛋白的加工:受调节蛋白磷酸化的试剂调控
Proc Natl Acad Sci U S A. 1990 Aug;87(15):6003-6. doi: 10.1073/pnas.87.15.6003.
8
Phosphorylation of the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein at Ser655 by a novel protein kinase.一种新型蛋白激酶使阿尔茨海默病β-淀粉样前体蛋白的胞质结构域在丝氨酸655位点发生磷酸化。
Biochem Biophys Res Commun. 1999 May 10;258(2):300-5. doi: 10.1006/bbrc.1999.0637.
9
Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system.阿尔茨海默病β-淀粉样前体蛋白的代谢:完整细胞和无细胞系统中蛋白激酶A的调节作用
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4081-4. doi: 10.1073/pnas.93.9.4081.
10
Amyloid precursor protein secretion and beta A4 amyloid generation are not mutually exclusive.
FEBS Lett. 1994 Aug 1;349(2):210-4. doi: 10.1016/0014-5793(94)00671-7.

引用本文的文献

1
Comparing In vitro Protein Aggregation Modelling Using Strategies Relevant to Neuropathologies.使用与神经病理学相关的策略比较体外蛋白质聚集模型
Cell Mol Neurobiol. 2025 Mar 13;45(1):24. doi: 10.1007/s10571-025-01539-z.
2
rs744373 SNP and alleles specifically associate to common diseases.rs744373单核苷酸多态性及等位基因与常见疾病存在特异性关联。
Front Dement. 2022 Oct 28;1:1001113. doi: 10.3389/frdem.2022.1001113. eCollection 2022.
3
Novel therapeutic strategies targeting mitochondria as a gateway in neurodegeneration.靶向线粒体作为神经退行性变切入点的新型治疗策略。
Neural Regen Res. 2023 May;18(5):991-995. doi: 10.4103/1673-5374.355750.
4
A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.一种生物信息学方法,揭示阿尔茨海默病与糖尿病之间的突触分子串扰。
J Alzheimers Dis. 2022;86(4):1917-1933. doi: 10.3233/JAD-215059.
5
Phosphorylation Signaling in APP Processing in Alzheimer's Disease.阿尔茨海默病中 APP 处理的磷酸化信号转导。
Int J Mol Sci. 2019 Dec 27;21(1):209. doi: 10.3390/ijms21010209.
6
Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.跨物种基因筛选以鉴定阿尔茨海默病中 APP 减少的激酶靶标。
Hum Mol Genet. 2019 Jun 15;28(12):2014-2029. doi: 10.1093/hmg/ddz034.
7
Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer's Disease.死亡相关蛋白激酶 1 作为癌症和阿尔茨海默病的有前途的药物靶点。
Recent Pat Anticancer Drug Discov. 2019;14(2):144-157. doi: 10.2174/1574892814666181218170257.
8
Disease-Modifying Effects of M Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model.M型毒蕈碱型乙酰胆碱受体激活在阿尔茨海默病小鼠模型中的疾病修饰作用。
ACS Chem Neurosci. 2017 Jun 21;8(6):1177-1187. doi: 10.1021/acschemneuro.6b00278. Epub 2017 Mar 7.
9
The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment.蛋白磷酸酶-2A 的抑制剂-2 的羧基末端片段可诱导阿尔茨海默病病理和认知障碍。
FASEB J. 2010 Nov;24(11):4420-32. doi: 10.1096/fj.10-158477. Epub 2010 Jul 22.
10
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.II 型代谢型谷氨酸受体刺激会引发分离完整神经末梢中阿尔茨海默病淀粉样β(β)42 的产生和释放。
J Neurosci. 2010 Mar 17;30(11):3870-5. doi: 10.1523/JNEUROSCI.4717-09.2010.